Patents Assigned to IVIEW Therapeutics (Zhuhai) Co., Ltd.
  • In-situ Gel Forming Ophthalmic Formulations Containing Difluprednate
    Publication number: 20230172946
    Abstract: The present invention provides aqueous in-situ gel ophthalmic formulations, each including water, difluprednate and a biocompatible polysaccharide, wherein a gel is formed in situ at physiological temperature with instant viscosity increase upon instillation of the formulation into an eye. In the formulations, nanocarriers may be formed by a surfactant or solubilizer contained in the formulation, with or encapsulating difluprednate, and the nanocarriers have an average particle size of 10 to 500 nm or 10 to 150 nm or 10- to 50 nm.
    Type: Application
    Filed: August 18, 2020
    Publication date: June 8, 2023
    Applicants: IVIEW Therapeutics, Inc., IVIEW Therapeutics (Zhuhai) Co., Ltd.
    Inventors: Bo Liang, Ming Zhang, Haizhou Peng
  • In-situ Gel Containing Cyclosporine Micelles as Sustained Ophthalmic Drug Delivery System
    Publication number: 20230093908
    Abstract: The present invention provides aqueous ophthalmic formulations containing 0.01%-5% by weight of cyclosporine which exists in the form of micelles having a particle size not greater than 20 nm, and methods of making and using such formulations.
    Type: Application
    Filed: August 18, 2020
    Publication date: March 30, 2023
    Applicant: IVIEW Therapeutics (Zhuhai) Co., Ltd.
    Inventors: Bo Liang, Haizhou Peng, Jieyu Zhu, Xudong Yuan